Ridhima Vij

3PUBLICATIONS
6CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 15, 2026
Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical Trial.

|Oct 05, 2023
Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program.

Ridhima Vij, Hosu Kim, Hyeonggeun Park

|Mar 04, 2022
Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial.

Ridhima Vij, Kevin A Stebbings, Hosu Kim

Pageof 1

Frequent Collaborators

1 joint publications

Kevin A Stebbings

1 joint publications

Hosu Kim

1 joint publications

Hyeonggeun Park

1 joint publications

Djamchid Lotfi